Multi-licensed, first-to-market UK cannabis importer and distributor seeks strategic equity partner!

Phase 1

• Import and distribution of high-quality, low-cost, branded cannabis flower and oil products for UK medical cannabis patients via exclusive UK pharmacy contracts

• Exclusive contracts with well-established, top ranked Canadian and global medical cannabis producers, with market proven products

• Access to a large and increasing pool of medicinal cannabis patients through in-house and partner health clinics, pharmacies and other key relationships

• Product launch via dedicated sales and marketing team, with first revenues in Q4 of 2023

• Experienced, industry-leading international team with deep expertise in navigating global medical cannabis markets

• $1M USD projected annual sales in 2023, with $10M USD sales projected in 2024

• No growing

• No capital required for infrastructure

• All licenses in place

• Turn key operation

Phase 2

• Expansion of wholesale distribution of branded cannabis flower, oils and derivative products to the European Union and global markets via a partner facility in Ireland.

• Implementation of in-house EU GMP production in the UK/Channel Islands for direct distribution into the UK and EU markets